Home >> Marketplace Directory >> Beckman Coulter Life Sciences, AmoyDx ink agreement

Beckman Coulter Life Sciences, AmoyDx ink agreement

image_pdfCreate PDF

April 2022—Beckman Coulter Life Sciences has entered into an agreement with AmoyDx to develop applications on the Biomek NGenius liquid handling system. The Biomek NGenius system is scheduled to launch in the second quarter of this year; it is not intended or validated for use in diagnosis of disease or other conditions.

CAP TODAY
X